We checked the expression of EMT markers, cell migration, and cell growth in PC-3 cells using AKT siRNA to assess whether the targeting AKT contributed to the anti-cancer effect in AR-independent prostate cancer cells, PC-3 cells. Here, AR is linked to prostate carcinoma.